vs

Side-by-side financial comparison of Booz Allen Hamilton Holding Corp (BAH) and Invesco (IVZ). Click either name above to swap in a different company.

Booz Allen Hamilton Holding Corp is the larger business by last-quarter revenue ($2.6B vs $1.7B, roughly 1.5× Invesco). Booz Allen Hamilton Holding Corp runs the higher net margin — 7.6% vs -58.9%, a 66.5% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs -10.2%). Invesco produced more free cash flow last quarter ($432.2M vs $248.0M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs -2.8%).

Booz Allen Hamilton Holding Corporation is the parent of Booz Allen Hamilton Inc., an American company specializing in digital transformation and artificial intelligence. The company is headquartered in McLean, Virginia, in the Washington metropolitan area, with 80 additional offices around the globe. Booz Allen's stated core business is to provide consulting, analysis, and engineering services to public- and private-sector organizations and nonprofits.

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

BAH vs IVZ — Head-to-Head

Bigger by revenue
BAH
BAH
1.5× larger
BAH
$2.6B
$1.7B
IVZ
Growing faster (revenue YoY)
IVZ
IVZ
+16.4% gap
IVZ
6.2%
-10.2%
BAH
Higher net margin
BAH
BAH
66.5% more per $
BAH
7.6%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$184.2M more FCF
IVZ
$432.2M
$248.0M
BAH
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
-2.8%
BAH

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BAH
BAH
IVZ
IVZ
Revenue
$2.6B
$1.7B
Net Profit
$200.0M
$-995.9M
Gross Margin
51.9%
Operating Margin
8.8%
-86.2%
Net Margin
7.6%
-58.9%
Revenue YoY
-10.2%
6.2%
Net Profit YoY
7.0%
-575.8%
EPS (diluted)
$1.63
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAH
BAH
IVZ
IVZ
Q4 25
$2.6B
$1.7B
Q3 25
$2.9B
$1.6B
Q2 25
$2.9B
$1.5B
Q1 25
$3.0B
$1.5B
Q4 24
$2.9B
$1.6B
Q3 24
$3.1B
$1.5B
Q2 24
$2.9B
$1.5B
Q1 24
$2.8B
$1.5B
Net Profit
BAH
BAH
IVZ
IVZ
Q4 25
$200.0M
$-995.9M
Q3 25
$175.0M
$356.4M
Q2 25
$271.0M
$197.4M
Q1 25
$192.7M
$171.1M
Q4 24
$186.9M
$209.3M
Q3 24
$390.1M
$55.0M
Q2 24
$165.2M
$132.2M
Q1 24
$128.0M
$141.5M
Gross Margin
BAH
BAH
IVZ
IVZ
Q4 25
51.9%
Q3 25
53.6%
Q2 25
51.3%
Q1 25
53.6%
Q4 24
55.2%
Q3 24
56.7%
Q2 24
53.4%
Q1 24
54.7%
Operating Margin
BAH
BAH
IVZ
IVZ
Q4 25
8.8%
-86.2%
Q3 25
9.8%
16.5%
Q2 25
8.8%
14.1%
Q1 25
9.2%
18.1%
Q4 24
10.0%
19.6%
Q3 24
17.4%
6.6%
Q2 24
8.7%
13.9%
Q1 24
9.5%
14.4%
Net Margin
BAH
BAH
IVZ
IVZ
Q4 25
7.6%
-58.9%
Q3 25
6.1%
21.7%
Q2 25
9.3%
13.0%
Q1 25
6.5%
11.2%
Q4 24
6.4%
13.1%
Q3 24
12.4%
3.6%
Q2 24
5.6%
8.9%
Q1 24
4.6%
9.6%
EPS (diluted)
BAH
BAH
IVZ
IVZ
Q4 25
$1.63
$-2.61
Q3 25
$1.42
$0.66
Q2 25
$2.16
$-0.03
Q1 25
$1.52
$0.38
Q4 24
$1.45
$0.46
Q3 24
$3.01
$0.12
Q2 24
$1.27
$0.29
Q1 24
$0.97
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAH
BAH
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$882.0M
$1.0B
Total DebtLower is stronger
$3.9B
$1.8B
Stockholders' EquityBook value
$1.0B
$12.2B
Total Assets
$7.1B
$27.1B
Debt / EquityLower = less leverage
3.84×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAH
BAH
IVZ
IVZ
Q4 25
$882.0M
$1.0B
Q3 25
$816.0M
$973.1M
Q2 25
$711.0M
$922.7M
Q1 25
$885.0M
$821.7M
Q4 24
$453.5M
$986.5M
Q3 24
$558.7M
$1.0B
Q2 24
$297.7M
$878.5M
Q1 24
$554.3M
$895.7M
Total Debt
BAH
BAH
IVZ
IVZ
Q4 25
$3.9B
$1.8B
Q3 25
$4.0B
$1.6B
Q2 25
$4.0B
$1.9B
Q1 25
$4.0B
$964.8M
Q4 24
$3.4B
$890.6M
Q3 24
$3.4B
$890.3M
Q2 24
$3.4B
$890.1M
Q1 24
$3.4B
$1.3B
Stockholders' Equity
BAH
BAH
IVZ
IVZ
Q4 25
$1.0B
$12.2B
Q3 25
$996.0M
$14.0B
Q2 25
$1.1B
$13.9B
Q1 25
$1.0B
$14.7B
Q4 24
$1.2B
$14.6B
Q3 24
$1.2B
$14.8B
Q2 24
$1.1B
$14.6B
Q1 24
$1.0B
$14.6B
Total Assets
BAH
BAH
IVZ
IVZ
Q4 25
$7.1B
$27.1B
Q3 25
$7.2B
$28.4B
Q2 25
$7.2B
$28.5B
Q1 25
$7.3B
$28.1B
Q4 24
$6.8B
$27.0B
Q3 24
$6.9B
$27.5B
Q2 24
$6.6B
$27.2B
Q1 24
$6.6B
$28.1B
Debt / Equity
BAH
BAH
IVZ
IVZ
Q4 25
3.84×
0.15×
Q3 25
3.98×
0.12×
Q2 25
3.74×
0.14×
Q1 25
3.99×
0.07×
Q4 24
2.79×
0.06×
Q3 24
2.83×
0.06×
Q2 24
3.14×
0.06×
Q1 24
3.26×
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAH
BAH
IVZ
IVZ
Operating Cash FlowLast quarter
$261.0M
$455.8M
Free Cash FlowOCF − Capex
$248.0M
$432.2M
FCF MarginFCF / Revenue
9.5%
25.5%
Capex IntensityCapex / Revenue
0.5%
1.4%
Cash ConversionOCF / Net Profit
1.30×
TTM Free Cash FlowTrailing 4 quarters
$933.4M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAH
BAH
IVZ
IVZ
Q4 25
$261.0M
$455.8M
Q3 25
$421.0M
$606.2M
Q2 25
$119.0M
$547.9M
Q1 25
$219.0M
$-84.6M
Q4 24
$150.8M
$316.9M
Q3 24
$587.1M
$438.4M
Q2 24
$52.1M
$489.1M
Q1 24
$143.8M
$-54.4M
Free Cash Flow
BAH
BAH
IVZ
IVZ
Q4 25
$248.0M
$432.2M
Q3 25
$395.0M
$586.4M
Q2 25
$96.0M
$530.4M
Q1 25
$194.4M
$-108.0M
Q4 24
$133.6M
$309.9M
Q3 24
$563.3M
$410.0M
Q2 24
$19.7M
$462.4M
Q1 24
$127.6M
$-75.4M
FCF Margin
BAH
BAH
IVZ
IVZ
Q4 25
9.5%
25.5%
Q3 25
13.7%
35.7%
Q2 25
3.3%
35.0%
Q1 25
6.5%
-7.1%
Q4 24
4.6%
19.5%
Q3 24
17.9%
27.1%
Q2 24
0.7%
31.2%
Q1 24
4.6%
-5.1%
Capex Intensity
BAH
BAH
IVZ
IVZ
Q4 25
0.5%
1.4%
Q3 25
0.9%
1.2%
Q2 25
0.8%
1.2%
Q1 25
0.8%
1.5%
Q4 24
0.6%
0.4%
Q3 24
0.8%
1.9%
Q2 24
1.1%
1.8%
Q1 24
0.6%
1.4%
Cash Conversion
BAH
BAH
IVZ
IVZ
Q4 25
1.30×
Q3 25
2.41×
1.70×
Q2 25
0.44×
2.78×
Q1 25
1.14×
-0.49×
Q4 24
0.81×
1.51×
Q3 24
1.50×
7.97×
Q2 24
0.32×
3.70×
Q1 24
1.12×
-0.38×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BAH
BAH

Defense Clients$1.5B55%
Civil Clients$732.0M28%
Intelligence Clients$434.0M17%

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons